- Home
- INM vs CINGW Comparison
INM vs CINGW Comparison
Compare INM & CINGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- CINGW
- Stock Information
- Founded
- INM 1981
- CINGW N/A
- Country
- INM Canada
- CINGW United States
- Employees
- INM N/A
- CINGW 13
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- CINGW Biotechnology: Pharmaceutical Preparations
- Sector
- INM Health Care
- CINGW Health Care
- Exchange
- INM Nasdaq
- CINGW Nasdaq
- Market Cap
- INM 3.2M
- CINGW N/A
- IPO Year
- INM N/A
- CINGW 2021
- Fundamental
- Price
- INM $2.98
- CINGW $0.03
- Analyst Decision
- INM
- CINGW
- Analyst Count
- INM 0
- CINGW 0
- Target Price
- INM N/A
- CINGW N/A
- AVG Volume (30 Days)
- INM 55.8K
- CINGW N/A
- Earning Date
- INM 05-13-2025
- CINGW N/A
- Dividend Yield
- INM N/A
- CINGW N/A
- EPS Growth
- INM N/A
- CINGW N/A
- EPS
- INM N/A
- CINGW N/A
- Revenue
- INM $4,832,013.00
- CINGW N/A
- Revenue This Year
- INM N/A
- CINGW N/A
- Revenue Next Year
- INM N/A
- CINGW N/A
- P/E Ratio
- INM N/A
- CINGW N/A
- Revenue Growth
- INM N/A
- CINGW N/A
- 52 Week Low
- INM $1.72
- CINGW N/A
- 52 Week High
- INM $15.70
- CINGW N/A
- Technical
- Relative Strength Index (RSI)
- INM 60.92
- CINGW N/A
- Support Level
- INM $2.56
- CINGW N/A
- Resistance Level
- INM $3.15
- CINGW N/A
- Average True Range (ATR)
- INM 0.28
- CINGW 0.00
- MACD
- INM 0.09
- CINGW 0.00
- Stochastic Oscillator
- INM 88.11
- CINGW 0.00
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
About CINGW Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.